However, there would also need to be an extended period of longitudinal analysis of the effects of the therapy on the experimental group mice's health to see if the improvement continued and did not produce damaging side effects.

The MSCs in the liver therapy are not derived from human embryos and thus the objections to discarding human embryos are not a factor in the ethical discussion about the therapy. In fact, "the number of MSCs that can be obtained from a donor is significantly lower than the number needed for tissue regeneration. Therefore, MSCs are expanded ex-vivo in media supplemented with growth factors" and created in a lab ("MSC growth factors," R&D Systems, 2013). The main ethical objections to the use of MCSs revolve around the question of scientists' right to create new organs and the possible risks involved. The Japanese research team "relied on a 'cocktail' of so-called induced...
[ View Full Essay]